%20--%3e%3c!DOCTYPE%20svg%20PUBLIC%20'-//W3C//DTD%20SVG%201.1//EN'%20'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'%20[%20%3c!ENTITY%20st0%20'fill:%23267E9A;'%3e%3c!ENTITY%20st1%20'fill:%2378C9DA;'%3e%3c!ENTITY%20st2%20'fill:%23FFFFFF;'%3e%3c!ENTITY%20st3%20'fill:%23085580;'%3e%3c!ENTITY%20st4%20'fill:%2386C34A;'%3e%3c!ENTITY%20st5%20'fill:%232FBBCC;'%3e%3c!ENTITY%20st6%20'fill:%234C6F90;'%3e%3c!ENTITY%20st7%20'fill:%23194670;'%3e%3c!ENTITY%20st8%20'fill:%2307557E;'%3e%3c!ENTITY%20st9%20'fill:%23516E89;'%3e%20]%3e%3csvg%20version='1.1'%20id='Layer_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%2032%2032'%20style='enable-background:new%200%200%2032%2032;'%20xml:space='preserve'%3e%3cg%3e%3cg%3e%3crect%20x='10.3'%20y='14'%20style='&st5;'%20width='5'%20height='4.4'/%3e%3crect%20x='10.3'%20y='12'%20style='&st5;'%20width='11.4'%20height='1'/%3e%3crect%20x='16.4'%20y='14'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='15.8'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='17.5'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='19.3'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='10.3'%20y='19.3'%20style='&st5;'%20width='5'%20height='0.9'/%3e%3cg%3e%3cpath%20style='&st5;'%20d='M22.6,22.3H9.4c-0.6,0-1.2-0.5-1.2-1.2v-10c0-0.6,0.5-1.2,1.2-1.2h13.1c0.6,0,1.2,0.5,1.2,1.2v10%20C23.7,21.7,23.2,22.3,22.6,22.3z%20M9.4,10.8c-0.1,0-0.3,0.1-0.3,0.3v10c0,0.1,0.1,0.3,0.3,0.3h13.1c0.1,0,0.3-0.1,0.3-0.3v-10%20c0-0.1-0.1-0.3-0.3-0.3H9.4z'/%3e%3c/g%3e%3c/g%3e%3cpath%20style='&st5;'%20d='M16,30.2C8.2,30.2,1.8,23.8,1.8,16S8.2,1.8,16,1.8S30.2,8.2,30.2,16S23.8,30.2,16,30.2z%20M16,2.8%20C8.7,2.8,2.8,8.7,2.8,16S8.7,29.2,16,29.2S29.2,23.3,29.2,16S23.3,2.8,16,2.8z'/%3e%3c/g%3e%3c/svg%3e)
Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
AI News
10/21/2026
AIDealsDiagnosticESCRSMeetingNewsletter
Futures Forum Highlights Higher Investment Bar, Looks at AI Concerns
A common theme at the 2026 Ophthalmology Futures European Forum was that capital and innovation remain available, but the bar for both has risen. The forum was held Sept. 10 at Glaziers Hall on the...
10/21/2026
AIESCRSMeetingNewsletter
ESCRS iNovation Day Spotlights Tech Boom and Barriers to Adoption
ESCRS iNovation Day showcased a broad pipeline of ophthalmic technologies, but companies expressed concerns over the economic climate. The forum was held Sept. 11, ahead of the ESCRS program in Lon...
10/21/2026
AICataractDiagnosticDigitalDry EyeEmergingIOLMyopiaNewsletterOculomicsRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, October 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
10/21/2026
AIDiagnosticNewsletterOculomics
Weekly Poll of MDs, US and Western Europe, October 2026
9/22/2026
AIDiagnosticDigitalNewsletter
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Manufacturers have invested heavily in AI, cloud connectivity, and digital applications over the past several years. These developments are continuing, but AI and digitalization are becoming less d...
9/22/2026
AIDiagnosticEmergingLow VisionNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, September 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
9/22/2026
AIChinaDealsDry EyeEuropeGlaucomaIOLIndustryLow VisionMyopiaNewsletterPharmaPresbyopiaRetinaSurgical
September 2026 Ophthalmic News Briefs
UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL. The lens will be available commercially in the EU in Q4-2026. The original Galaxy spiral IOL, a full range of visio...
9/4/2026
AIBreakingDiagnosticSurgical
AI Replaces Presurgical Scans in Removal of Sight-Threatening Brain Tumor
The European Medical Journal reported Aug. 28 that artificial intelligence had provided real-time guidance for removal of a vision-threatening brain tumor at University College London Hospital (UCL...
9/4/2026
AIBreakingDeviceDiagnosticRegulation
US FDA Asks for Feedback on GenAI Medical Device Regulation
The US FDA took inspiration from the way human clinicians are trained in drafting a proposal for the regulation of medical devices that feature generative artificial intelligence (GenAI), and it’s ...
7/24/2026
AIBreakingPharmaRegulation
Kalshi Offers Betting on Drug Development Timelines and Results
Prediction market Kalshi began on July 16 offering betting on a range of drug development milestones, ranging from clinical trial outcomes and timelines for submissions to US FDA decisions. The New...
7/21/2026
AIMeetingNewsletterRobotics
WOC 2026 Explores How AI Can Expand Access to Eye Care
Artificial intelligence is quickly evolving from a diagnostic tool into a comprehensive clinical assistant with the potential to expand access to eye care worldwide, as emphasized at the 2026 World...
7/21/2026
AIGlaucomaMeetingNewsletter
Octane Analyzes How AI and Practice Workflow are Driving Tech Innovation
The 2026 Octane Ophthalmology Tech Forum focused on how advances in artificial intelligence and physician workflow are influencing the develop-ment and commercialization of new ophthalmic technolog...
7/21/2026
AICataractChinaDealsDiagnosticDigitalFundusGlaucomaIOLIndustryNewsletterPharmaRefractiveRegulationRetinaSurgical
July 2026 Ophthalmic News Briefs
Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution for its Acuvue con...
7/10/2026
AIBreakingCataractDigitalSurgical
Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education
Bausch + Lomb reported July 9 the introduction of Orphia, a new AI-powered digital health platform intended to increase eye care providers’ efficiency. It will initially provide pre-surgery catarac...
6/18/2026
AIClinical TrialDealsEyeceleratorFundingMeetingNewsletterRegulation
Eyecelerator@ARVO and All Access Saturday Look at Business Side of Developing Therapeutics
May 1 marked the start of a new era for Eyecelerator, the organizer of ophthalmology innovation business conferences. It was the first time Eyecelerator was officially part of ARVO (Association for...
6/18/2026
AIClinical TrialDiagnosticDigitalMeetingNewsletter
AI Sessions at 2026 ARVO Meeting Move Past the Hype
The conversation around AI in ophthalmology has evolved over the past three years. The emphasis at the 2026 ARVO meeting and the Focus A-Eye Summit was on how to bridge the gap between innovation a...
6/18/2026
AIAllergyAmblyopiaCataractClinical TrialDealsDiagnosticIOLIndustryLaserMicroscopesMyopiaNewsletterOptometryPharmaRegulationRetinaSingle-UseSurgical
June 2026 Ophthalmic News Briefs
UK-based Rayner announced June 1 the launch of Ophteis Cohesive, a new OVD formulated with a high molecular weight to optimize space creation and ease of removal. Ophteis Cohesive is packaged at 1....
6/12/2026
AIBreakingDealsDigital
AAO Licenses Clinical Practice Guidelines to OpenEvidence Chatbot for Doctors
The American Academy of Ophthalmology reported June 9 that it had licensed the guidance in itsPreferred Practice Patterns and Ophthalmic Technology Assessments to OpenEvidence for its medical AI pl...
4/21/2026
AIDiagnosticDigitalEuropeNewsletter
Weekly Poll of MDs, US and Western Europe, April 2026
1/16/2026
AIBreakingDealsDiagnosticDigitalTelehealth
Topcon Healthcare Partners with RemoniHealth for Remote Eye Screening
Topcon Healthcare announced Jan. 13 a commercial partnership with RemoniHealth, of White Plains, New York, which provides remote monitoring of eye disease. No financial details were disclosed. Remo...
11/19/2025
AIBiosimilarsChinaClinical TrialDealsDiagnosticEuropeGene TherapyIndustryNewsletterPerimetryPresbyopiaRegulationRetinaThyroid Eye DiseaseUveitis
November 2025 Ophthalmic News Briefs
VEO Ophthalmics announced Oct. 16 that the VisionOne VR Visual Field platform is now available in the US through a strategic partnership with Switzerland’s PeriVision. No financial details about th...
10/31/2025
AIBreakingDealsDiagnosticPerimetry
VEO Ophthalmics Launches PeriVision’s VisionOne VR Visual Field Platform in US
VEO Ophthalmics announced Oct. 16 that the VisionOne VR Visual Field platform is now available in the US through a strategic partnership with Switzerland’s PeriVision. No financial details about th...
10/24/2025
AIBreakingDealsDiagnosticOculomics
Topcon Healthcare to Acquire AI Screening Company Toku
Topcon Healthcare announced Oct. 17 that it had signed a definitive agreement to acquire Toku, an artificial intelligence (AI) health technology company originally founded in New Zealand. No financ...
10/23/2025
AIDealsDiagnosticNewsletterRetina
EssilorLuxottica Acquires Screening Software Company RetinAI
Eyewear conglomerate EssilorLuxottica announced Oct. 15 that it would acquire Swiss company Ikerian, operating under the RetinAI brand. RetinAI develops tools to collect, process, and grade large-s...
10/23/2025
AIDealsDiagnosticEmergingEuropeGene TherapyGlaucomaIndiaMIGSNewsletterRetinaThyroid Eye DiseaseUveitis
Emerging Companies Pursuing Ophthalmic Indications, October 2025
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
10/17/2025
AIBreakingDealsDiagnosticRetina
EssilorLuxottica Acquires Screening Software Company RetinAI
Eyewear conglomerate EssilorLuxottica announced Oct. 15 that it would acquire Swiss company Ikerian, operating under the RetinAI brand. RetinAI develops tools to collect, process, and grade large-s...
9/22/2025
AIDiagnosticDigitalFundusMicroscopesNewsletter
AI Integration and Workflow Consolidation Drive Diagnostic Innovation
After years of steady hardware development, the ophthalmic diagnostic market is now oriented around two strategic imperatives: deep integration of artificial intelligence (AI) and consolidation of ...
9/22/2025
AICell TherapyCornealDealsDigitalFundingGene TherapyGlaucomaNewsletterRetinaSurgicalThyroid Eye Disease
Kriya Leads Latest Ophthalmic Fundraising with $320 Million in Series D
Kriya, of Durham, North Carolina, led recent ophthalmic fundraising efforts with a $320 million Series D round to fund its pipeline of gene therapy candidates. Financing announced in the past four ...
9/22/2025
AINewsletterRetinaStudy
Moran Celebrates Approval of AI Tech to Help Time Injections for Wet AMD
The John A. Moran Eye Center is celebrating European regulatory approval of AI technology that assists ophthalmologists in timing intravitreal injections in wet age-related macular degeneration (AM...
9/22/2025
AICell TherapyCornealDiagnosticDigitalEmergingNewsletterRetinaUveitis
Emerging Companies Pursuing Ophthalmic Indications, September 2025
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
9/5/2025
AIBreakingDiagnosticDigitalEuropeOCTRegulation
Zeiss Gains CE Marking for Cirrus PathFinder AI Tool With Automated OCT Analysis
Germany’s Carl Zeiss Meditec announced Aug. 21 that it had received CE marking in Europe for the Cirrus PathFinder, an artificial intelligence (AI) tool for analysis of optical coherence tomography...
8/20/2025
AIDealsDiagnosticDigitalNewsletterRetina
Topcon Acquires Retinal Screening Platform to Improve Bidirectional Referrals
Topcon Healthcare reported July 31 that it had acquired Intelligent Retinal Imaging Systems (IRIS), a Pensacola, Florida-based developer of cloud-based retinal screening technology. No financial de...
8/15/2025
AIBreakingDiagnosticDigitalPharmaRetina
Moran Celebrates Approval of AI Tech to Help Time Injections for Wet AMD
The John A. Moran Eye Center is celebrating European regulatory approval of AI technology that assists ophthalmologists in timing intravitreal injections in wet age-related macular degeneration (AM...
8/8/2025
AIBreakingDealsDiagnosticDigitalOculomicsRetina
Topcon Healthcare Acquires Retinal Screening Platform to Improve Bidirectional Referrals
Topcon Healthcare reported July 31 that it had acquiredIntelligent Retinal Imaging Systems (IRIS), a Pensacola, Florida-based developer of cloud-based retinal screening technology. No financial det...
8/8/2025
AIBreakingDiagnosticIndustryRetina
Aeye Health Appoints Pamela F. Gallin, MD, as Chief Medical Officer
Aeye Health announced July 31 that it had appointed Pamela F. Gallin, MD, as its chief medical officer. Gallin is a clinical professor of ophthalmology in pediatrics at the Morgan Stanley Children’...
7/22/2025
AIMeetingNewsletterRefractive
Octane Examines Changing Refractive Surgery Landscape
The 2025 Octane Ophthalmology Tech Forum examined why lens-based procedures are gaining momentum at the expense of traditional refractive surgery. It also looked at the pivotal role that artificial...
7/22/2025
AICataractFundingGene TherapyGlaucomaNewsletterPharmaRetinaSurgical
ForSight Leads Latest Ophthalmic Fundraising with $125 Million in Series B
Israel’s ForSight Robotics led recent ophthalmic fundraising efforts with $125 million in Series B funding as it prepares its robotic cataract surgery system for human trials. Financing announced i...
7/22/2025
AICell TherapyChinaDiagnosticEmergingGene TherapyNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, July 2025
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.